Clinical Trial Update: Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Plantago Ovata Husk (psyllium husk) for remission of metabolic syndrome in children and adolescents has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Plantago Ovata Husk (psyllium husk)

Snippet

Sponsor: Rottapharm Spain | Conditions: Metabolic Syndrome | Phase 2 | Status: TERMINATED